Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Income Tax Benefit Recognized for our Share-Based Compensation Arrangements

Compensation cost included in income from continuing operations, primarily selling, general and administrative expense, and the income tax benefit recognized for our share-based compensation arrangements is included below:

 

	Years Ended December 31,
	2024		2023		2022
	(In thousands)
Total share-based compensation cost	$	27,532	$	21,024	$	23,454
Income tax benefit	6,553		5,004		5,582

Schedule of Fair Values for SARs and Stock Options Estimated on Grant Date Using Black-Scholes-Merton Option-Pricing Formula Which Incorporates Assumptions

	Years Ended December 31,
	2024		2023			2022
	(In thousands, except weighted average fair value and assumptions)
Weighted-average fair value of SARs granted	n/a		$	39.44		$	21.85
Total intrinsic value of SARs exercised	5,696		12,229			4,384
Tax expense (benefit) from SARs exercised	(420)		660			678
Weighted-average fair value of restricted stock units granted	89.98		95.32			61.61
Total fair value of restricted stock units vested	14,031		19,821			16,830
Expected volatility	38.88	%	43.45		%	43.00		%
Expected term (in years)	2.9		5.7			5.6
Risk-free rate	4.40	%	4.26		%	1.89		%
Dividend yield	0.25	%	0.23		%	0.37		%

Schedule of Share Based Compensation Activity

	Stock Appreciation Rights						Restricted Stock Units
	Number	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value		Number	Weighted- Average Grant-Date Fair Value
	(In thousands, except exercise prices, fair values, and contractual terms)
Outstanding at January 1, 2024	413	$	64.97	6.6	$	6,220	699	$	71.95
Granted	—	—					467	89.98
Exercised or converted	(143)	61.94					(254)	55.18
Forfeited or expired	(7)	77.60					(21)	76.74
Outstanding at December 31, 2024	263	$	66.29	6.5	$	12,199	891	$	83.35
Exercisable or convertible at December 31, 2024	167	$	60.66	5.7	$	8,696